Osmotherapy: use among neurointensivists (Q28300771)

1

0 references

Christos Lazaridis

2

0 references

Ron Neyens

3

0 references

Joyce Nicholas

4

0 references

Sarah Gay

5

0 references

Julio A Chalela

https://scigraph.springernature.com/pub.10.1007/s12028-010-9477-4

6

0 references

language of work or name

English

0 references

publication date

April 2011

0 references

published in

Neurocritical Care

0 references

volume

14

0 references

issue

2

0 references

page(s)

222-8

0 references

exact match

0 references

cites work

Osmotherapy in neurocritical care

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Osmotherapy. Basic concepts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Continuous regional cerebral blood flow monitoring in the neurosurgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Osmotic therapy: fact and fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Management of intracranial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Hypertonic saline: first-line therapy for cerebral edema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Prehospital Hypertonic Saline/Dextran Infusion for Post-traumatic Hypotension The U.S.A. Multicenter Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Mechanisms of action of hypertonic saline resuscitation in severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Hypertonic saline solutions for treatment of intracranial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Neurosurgical implications of mannitol accumulation within a meningioma and its peritumoral region demonstrated by magnetic resonance spectroscopy: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Chemical shift imaging of mannitol in acute cerebral ischemia. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury--a study of cerebral blood flow and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Effect of equiosmolar solutions of mannitol versus hypertonic saline on intraoperative brain relaxation and electrolyte balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9477-4

Linear correlation between stable intracranial pressure decrease and regional cerebral oxygenation improvement following mannitol administration in severe acute head injury patients.

21 January 2018

1 reference

12 December 2020

Malignant cerebral edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: a rebound phenomenon?

1 reference

12 December 2020

Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. A study on 21 patients.

1 reference

12 December 2020

Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy.

1 reference

12 December 2020

Cerebral blood flow and rheologic alterations by hyperosmolar therapy in patients with brain oedema

1 reference

12 December 2020

Slowing of peroxynitrite decomposition in the presence of mannitol and ethanol

1 reference

12 December 2020

Hypernatremia in the neurologic intensive care unit: how high is too high?

1 reference

12 December 2020

The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial

1 reference

12 December 2020

Renal, cerebral, and pulmonary effects of hypertonic resuscitation in a porcine model of hemorrhagic shock

1 reference

12 December 2020

Mannitol decreases ICP but does not improve brain-tissue pO2 in severely head-injured patients with intracranial hypertension.

1 reference

12 December 2020

Prehospital Hypertonic Saline Resuscitation of Patients With Hypotension and Severe Traumatic Brain Injury

1 reference

12 December 2020